Office of Research

Implementation and Outcomes Research

Limited Submissions

This grant opportunity is intended to support innovative investigators from companies, research institutions, and other eligible organizations to translate promising research and scientific discoveries into the development of tools, devices, technologies, therapeutics, or interventions related to cancer. This request for proposals (RFP) seeks applications that are focused on the development and implementation or translation of innovative ideas that have the potential to address important needs related to cancer prevention, screening, detection, treatment, and survivorship and that will ultimately advance cancer care, lessen the burden of cancer, and improve health outcomes. 

Proposed projects should be focused on implementing or translating research findings into a cancer-related product or technology or evaluating the outcomes of implementing scientific discoveries in cancer research. Projects may be anywhere along the implementation translational cancer research continuum, from proof-of-concept research to product launch and commercialization to implementation of an intervention. Projects should be additive to current understanding and seek to create new knowledge. Projects that include a provision of services that includes quantifiable outcomes data suitable for efficacy research are eligible. 

A portion of administrative costs for essential product development and commercialization activities may be allowed but only if they are not the primary focus of the project. Projects that primarily seek funding for advertisement and promotion for commercialization, without seeking to create knowledge, are not aligned with the program’s purpose.

Application Instructions

Please submit:

  1. A one‐page letter of intent with a description of proposed aims and approach.
  2. If the final application requires a diversity statement or statement of broader impacts, please summarize your plans to address the specific requirements on an additional page.
  3. CV (not biosketch) of the PI including past grant funding.

to limitedsubs@uw.edu by 5:00 PM Wednesday, July 10, 2024. Proposals are due to the sponsor 8/13/2024, so you will need to have your materials in to the Office of Sponsored Programs by 8/2/2024 if given the go‐ahead by the Limited Submissions review committee.

Opportunity Details

Program web page

Program Announcement No.

2024

Deadlines
07/10/2024 UW Internal Deadline Closed
08/02/2024 OSP Deadline
08/13/2024 Sponsor Deadline
Sponsor

Washington's Cancer Research Endowment (CARE) Fund

Funding amount

$1,500,000 (grant requires 1:1 matching funds from a non-state of Washington source)

Maximum Number of Applications

5

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.